HAW/240
Generic Name: carbetapentane/guaifenesin
Pill imprint HAW/240 has been identified as Xpect-AT 60 mg-600 mg.
Xpect-AT is used in the treatment of cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy.
Xpect-AT 60 mg-600 mg is not subject to the Controlled Substances Act.
See also related documents.
Xpect-AT Images
- Generic Name:
- carbetapentane/guaifenesin
- Imprint:
-
HAW/240
- Strength:
- 60 mg-600 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Hawthorn Pharmaceuticals
More Xpect-AT resources
- Xpect-AT Sustained-Release Tablets (Wolters Kluwer)
- Xpect-AT (Cerner Multum)


